BlackRock’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.02B Buy
11,277,914
+745,520
+7% +$63.2M 0.02% 764
2026
Q1
$880M Sell
10,532,394
-683,435
-6% -$56.1M 0.02% 754
2025
Q4
$1.03B Buy
11,215,829
+49,971
+0.4% +$4.78M 0.02% 675
2025
Q3
$1.06B Buy
11,165,858
+441,876
+4% +$41.6M 0.02% 653
2025
Q2
$1.12B Sell
10,723,982
-144,118
-1% -$13.7M 0.02% 596
2025
Q1
$960M Sell
10,868,100
-111,387
-1% -$11.4M 0.02% 643
2024
Q4
$1.05B Buy
10,979,487
+37,817
+0.3% +$3.52M 0.02% 610
2024
Q3
$896M Buy
10,941,670
+202,177
+2% +$15.6M 0.02% 695
2024
Q2
$926M Sell
10,739,493
-186,714
-2% -$15.1M 0.02% 626
2024
Q1
$892M Buy
10,926,207
+334,286
+3% +$26.1M 0.02% 659
2023
Q4
$702M Buy
10,591,921
+560,485
+6% +$38.9M 0.02% 765
2023
Q3
$733M Sell
10,031,436
-314,844
-3% -$21.3M 0.02% 673
2023
Q2
$653M Buy
10,346,280
+58,684
+0.6% +$3.4M 0.02% 761
2023
Q1
$604M Sell
10,287,596
-135,383
-1% -$8.22M 0.02% 793
2022
Q4
$642M Buy
10,422,979
+732,479
+8% +$49.2M 0.02% 727
2022
Q3
$651M Sell
9,690,500
-80,955
-0.8% -$5.12M 0.02% 674
2022
Q2
$600M Buy
9,771,455
+348,447
+4% +$22.3M 0.02% 735
2022
Q1
$635M Buy
9,423,008
+358,743
+4% +$19.4M 0.02% 801
2021
Q4
$401M Buy
9,064,265
+59,190
+0.7% +$3.45M 0.01% 1213
2021
Q3
$583M Sell
9,005,075
-48,402
-0.5% -$3.36M 0.02% 868
2021
Q2
$729M Sell
9,053,477
-380,882
-4% -$29M 0.02% 754
2021
Q1
$642M Buy
9,434,359
+426,446
+5% +$33.5M 0.02% 807
2020
Q4
$628M Buy
9,007,913
+336,327
+4% +$20.9M 0.02% 742
2020
Q3
$445M Buy
8,671,586
+189,130
+2% +$10.4M 0.02% 811
2020
Q2
$498M Buy
8,482,456
+189,588
+2% +$10.5M 0.02% 719
2020
Q1
$420M Sell
8,292,868
-618,762
-7% -$41.1M 0.02% 703
2019
Q4
$660M Buy
8,911,630
+291,388
+3% +$18.2M 0.03% 645
2019
Q3
$493M Buy
8,620,242
+1,351,557
+19% +$89.7M 0.02% 762
2019
Q2
$475M Buy
7,268,685
+840,177
+13% +$58.5M 0.02% 775
2019
Q1
$476M Sell
6,428,508
-335,763
-5% -$23.6M 0.02% 764
2018
Q4
$403M Buy
6,764,271
+109,127
+2% +$8.8M 0.02% 767
2018
Q3
$628M Sell
6,655,144
-1,033,624
-13% -$89M 0.03% 627
2018
Q2
$577M Buy
7,688,768
+777,915
+11% +$55.9M 0.03% 632
2018
Q1
$418M Buy
6,910,853
+159,362
+2% +$8.63M 0.02% 813
2017
Q4
$315M Buy
6,751,491
+244,819
+4% +$12.1M 0.02% 1044
2017
Q3
$329M Buy
6,506,672
+675,658
+12% +$31.5M 0.02% 951
2017
Q2
$291M Buy
5,831,014
+241,061
+4% +$11.3M 0.02% 1014
2017
Q1
$237M Buy
5,589,953
+5,586,414
+157,853% +$247M 0.01% 1145
2016
Q4
$143K Sell
3,539
-416
-11% -$16.1K ﹤0.01% 2338
2016
Q3
$150K Buy
3,955
+361
+10% +$11.4K ﹤0.01% 2349
2016
Q2
$109K Buy
3,594
+1,297
+56% +$34.1K ﹤0.01% 2483
2016
Q1
$57K Sell
2,297
-121
-5% -$2.59K ﹤0.01% 2298
2015
Q4
$61K Buy
2,418
+898
+59% +$27.6K ﹤0.01% 1950
2015
Q3
$45K Buy
1,520
+721
+90% +$22.7K ﹤0.01% 1949
2015
Q2
$26K Buy
+799
New +$21.4K ﹤0.01% 2275

Other funds holding HQY

BlackRock's HQY Position: Q2 2026 in Review

BlackRock increased its HealthEquity (HQY) stake by 7.1% in Q2 2026, buying an estimated $63.2M and bringing the position to 11,277,914 shares worth $1.02B. The position accounts for 0.02% of the portfolio, ranked #764.

BlackRock first reported a position in HQY in Q2 2015 and has held it in 45 quarters since. The position peaked at $1.12B in Q2 2025. 496 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • BlackRock held 11,277,914 shares of HealthEquity worth $1.02B as of Q2 2026.
  • BlackRock bought 745,520 HealthEquity shares in Q2 2026, an estimated $63.2M.
  • HealthEquity made up 0.02% of BlackRock's portfolio in Q2 2026, its #764 holding.
  • BlackRock first reported a position in HealthEquity in Q2 2015 and has held it in 45 quarters since.
  • BlackRock's HealthEquity position peaked at $1.12B in Q2 2025.
  • 496 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.